Inflammation primes the murine kidney for recovery by activating AZIN1 adenosine-to-inosine editing

Segewkal Heruye, Jered Myslinski, Chao Zeng, Amy Zollman, Shin‐ichi Makino, Azuma Nanamatsu, Quoseena Mir, Sarath Chandra Janga, Emma H. Doud, Michael T. Eadon, Bernhard Maier, Michiaki Hamada, Tuan M. Tran, Pierre C. Dagher, Takashi HatoJournal of Clinical Investigation 2024 · DOI

TL;DR

This study reveals that a specific type of RNA modification, adenosine-to-inosine (A-to-I) editing, particularly in the AZIN1 gene, acts as a crucial molecular clock and a trigger for kidney recovery following inflammatory injury. By activating AZIN1 editing, the kidney primes itself for endogenous repair mechanisms, enhancing polyamine synthesis, glycolysis, and nicotinamide biosynthesis.

What Problem Does This Paper Address?

Quantifying the progression and recovery phases of kidney disease, especially acute kidney injury (AKI), is notoriously difficult due to individual variability. The authors sought to identify a reliable, genome-wide "signature" that could delineate disease trajectories and predict recovery potential. They hypothesized that post-transcriptional RNA modifications, specifically adenosine-to-inosine (A-to-I) editing, could serve this purpose, given their role in regulating gene expression and cellular processes.

Methods

The researchers employed a multi-pronged approach:

  • Murine Model of Endotoxemia: A well-established model was used to induce controlled kidney inflammation and study the temporal dynamics of A-to-I editing.
  • RNA Sequencing (RNA-Seq): Used for genome-wide analysis of gene expression and to quantify A-to-I editing events.
  • CRISPR/Cas9 Gene Editing: Created genetically modified human cell lines (HEK293T) and mice with either constitutively edited AZIN1 (A-to-I locked) or uneditable AZIN1. This allowed for direct investigation of the functional consequences of AZIN1 editing.
  • Metabolomics: Analyzed the metabolic profiles of kidney tissues from edited and unedited mice to understand the biochemical pathways affected.
  • Polyribosome Profiling: Assessed global protein synthesis rates.
  • Immunoblotting and Western Blotting: Detected protein levels and modifications.
  • dsRNA Immunoprecipitation and Sequencing: Investigated the role of double-stranded RNA in triggering A-to-I editing.
  • Sanger Sequencing: Confirmed specific editing events.

Datasets

  • Human Malaria Cohort: RNA-Seq data from blood samples of children before and after malaria infection.
  • Human Kidney Biopsy Data: RNA-Seq data from kidney biopsies of patients with diabetic kidney disease (DKD), acute kidney injury (AKI), and reference nephrectomy samples.
  • Murine Endotoxemia Model Data: Comprehensive RNA-Seq, Ribo-Seq, dsRNA-Seq, and metabolomics data from kidney tissues at various time points post-LPS challenge.
  • Murine Ischemia/Reperfusion Injury (IRI) Model Data: RNA-Seq and metabolomics data from kidney tissues.
  • CRISPR-edited Cell Line Data: RNA-Seq and Seahorse glycolysis stress test data.
  • CRISPR-edited Mouse Model Data: RNA-Seq, metabolomics, and histological data.

Key Insights and Ideas

  • A-to-I Editing as a Molecular Clock: The study proposes that A-to-I editing, particularly at the AZIN1 locus, provides a precise temporal marker for different stages of kidney injury and recovery.
  • AZIN1 Editing as a Recovery Trigger: Inflammation doesn't just cause damage; it actively primes the kidney for repair by initiating AZIN1 A-to-I editing. This editing event is not merely a consequence but a driver of recovery.
  • Metabolic Reprogramming for Resilience: AZIN1 editing doesn't just boost polyamine synthesis; it orchestrates a broader metabolic shift, enhancing glycolysis and nicotinamide biosynthesis, which are crucial for cellular resilience and repair.
  • The "Primed" Kidney: The A-to-I-edited state appears to confer a "primed" status, making the kidney more robust against subsequent insults and better equipped for endogenous repair.

Key Results

  • AZIN1 A-to-I editing is prevalent and temporally regulated: It was observed in human malaria patients, kidney biopsies, and consistently in the murine endotoxemia and IRI models, with distinct temporal patterns.
  • AZIN1 A-to-I editing enhances polyamine biosynthesis: This is a known function, but the study shows it's critical for recovery.
  • A-to-I-locked cells/mice show improved resilience: In vitro, AZIN1-edited cells grew better under stress. In vivo, AZIN1-locked mice exhibited less severe kidney damage after IRI and faster tissue recovery.
  • Metabolic shifts are key: A-to-I editing in mice led to increased polyamines, NAD+, and AICAR, and upregulated genes involved in NAD+ salvage and the glycerol phosphate shuttle, all contributing to metabolic flexibility.
  • dsRNA stress precedes editing: The study identified an increase in double-stranded RNA (dsRNA) early in endotoxemia, which likely triggers ADAR enzymes responsible for A-to-I editing.

Limitations and Future Work

  • Mechanisms of Metabolic Flexibility: The precise mechanisms by which AZIN1 A-to-I editing induces metabolic reprogramming, beyond polyamine synthesis, require further investigation.
  • Polyamines' Versatility: The broad roles of polyamines in cellular processes make it challenging to pinpoint the exact pathways they influence in recovery.
  • Tissue and Injury Specificity: The role of AZIN1 editing might vary depending on the type of injury (e.g., sterile inflammation vs. infection) and the affected tissues.
  • Translational Challenges: Translating these findings to human diseases and developing AZIN1 A-to-I editing-based therapies remain significant challenges. The authors highlight the excitement around ADAR-based RNA editing technologies as a promising avenue.
  • Further Characterization of Isoforms: The role of specific ADAR isoforms, particularly Adar-201, in kidney editing warrants deeper exploration.

Summary updated

Abstract

The progression of kidney disease varies among individuals, but a general methodology to quantify disease timelines is lacking. Particularly challenging is the task of determining the potential for recovery from acute kidney injury following various insults. Here, we report that quantitation of post-transcriptional adenosine-to-inosine (A-to-I) RNA editing offers a distinct genome-wide signature, enabling the delineation of disease trajectories in the kidney. A well-defined murine model of endotoxemia permitted the identification of the origin and extent of A-to-I editing, along with temporally discrete signatures of double-stranded RNA stress and adenosine deaminase isoform switching. We found that A-to-I editing of antizyme inhibitor 1 (AZIN1), a positive regulator of polyamine biosynthesis, serves as a particularly useful temporal landmark during endotoxemia. Our data indicate that AZIN1 A-to-I editing, triggered by preceding inflammation, primes the kidney and activates endogenous recovery mechanisms. By comparing genetically modified human cell lines and mice locked in either A-to-I-edited or uneditable states, we uncovered that AZIN1 A-to-I editing not only enhances polyamine biosynthesis but also engages glycolysis and nicotinamide biosynthesis to drive the recovery phenotype. Our findings implicate that quantifying AZIN1 A-to-I editing could potentially identify individuals who have transitioned to an endogenous recovery phase. This phase would reflect their past inflammation and indicate their potential for future recovery.
BibTeX
@article{heruye2024inflammation,
  author = {Segewkal Heruye and Jered Myslinski and Chao Zeng and Amy Zollman and Shin‐ichi Makino and Azuma Nanamatsu and Quoseena Mir and Sarath Chandra Janga and Emma H. Doud and Michael T. Eadon and Bernhard Maier and Michiaki Hamada and Tuan M. Tran and Pierre C. Dagher and Takashi Hato},
  title = {{Inflammation primes the murine kidney for recovery by activating AZIN1 adenosine-to-inosine editing}},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci180117},
}
Figure